The CancerVax platform is designed to harness the body’s existing immunity to detect, mark, and kill cancer cells with ...

A new Northwestern Medicine study has uncovered how a key immunoregulatory receptor plays an unexpected dual role in ...

Scientists have uncovered new genetic rules that determine whether the immune system’s “killer” T cells remain powerful long-term defenders or become worn out and ineffective. By building a detailed ...

Clonally expanded CD8+ T cells are key drivers of alopecia areata, mediating epithelial cell death and immune infiltration. JAK inhibitors are approved for AA treatment, but recurrence is common, ...

Chimeric antigen receptor (CAR) T cell-based therapy has greatly improved cancer treatment, especially for hematologic cancers. 1 By providing T cells with synthetic receptors that target tumor ...

A major pillar of cancer immunotherapy involves stimulating T cells, the specialized killers of the immune system, to attack ...